{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:53:01Z","timestamp":1776315181510,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia","award":["FRGS\/1\/2018\/SKK09\/UM\/01\/1 (FP016-2018A)"],"award-info":[{"award-number":["FRGS\/1\/2018\/SKK09\/UM\/01\/1 (FP016-2018A)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00210-025-04890-6","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:17:43Z","timestamp":1765613863000},"page":"7505-7531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multifaceted anticancer mechanisms of tribenzyltin carboxylates: DNA minor groove targeting and inhibition of key enzymes in DNA replication, nucleotide synthesis, and redox homeostasis"],"prefix":"10.1007","volume":"399","author":[{"given":"Theebaa","family":"Anasamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiing Yee","family":"Foo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Shang","family":"Saw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee Chu","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuancheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon Han","family":"Heh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin Fei","family":"Chee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lik Voon","family":"Kiew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lip Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"4890_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2020.111266","volume":"214","author":"AA Adeleke","year":"2021","unstructured":"Adeleke AA, Islam MS, Sanni O, Mocktar C, Zamisa SJ, Omondi B (2021) Aryl variation and anion effect on CT-DNA binding and in vitro biological studies of pyridinyl Ag (I) complexes. J Inorg Biochem 214:111266. https:\/\/doi.org\/10.1016\/j.jinorgbio.2020.111266","journal-title":"J Inorg Biochem"},{"key":"4890_CR2","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.ejmech.2016.09.061","volume":"125","author":"T Anasamy","year":"2017","unstructured":"Anasamy T, Thy CK, Lo KM, Chee CF, Yeap SK, Kamalidehghan B, Chung LY (2017) Tribenzyltin carboxylates as anticancer drug candidates: effect on the cytotoxicity, motility and invasiveness of breast cancer cell lines. Eur J Med Chem 125:770\u2013783. https:\/\/doi.org\/10.1016\/j.ejmech.2016.09.061","journal-title":"Eur J Med Chem"},{"key":"4890_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105140","volume":"142","author":"T Anasamy","year":"2020","unstructured":"Anasamy T, Chee CF, Kiew LV, Chung LY (2020) In vivo antitumour properties of tribenzyltin carboxylates in a 4T1 murine metastatic mammary tumour model: enhanced efficacy by PLGA nanoparticles. Eur J Pharm Sci 142:105140. https:\/\/doi.org\/10.1016\/j.ejps.2019.105140","journal-title":"Eur J Pharm Sci"},{"key":"4890_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.6089","volume":"35","author":"T Anasamy","year":"2021","unstructured":"Anasamy T, Chee CF, Wong YF, Heh CH, Kiew LV, Lee HB, Chung LY (2021) Triorganotin complexes in cancer chemotherapy: mechanistic insights and future perspectives. Appl Organomet Chem 35:e6089. https:\/\/doi.org\/10.1002\/aoc.6089","journal-title":"Appl Organomet Chem"},{"key":"4890_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/computation12010003","volume":"12","author":"MN Arthur","year":"2024","unstructured":"Arthur MN, Bebla K, Broni E, Ashley C, Velazquez M, Hua X, Radhakrishnan R, Kwofie SK, Miller WA (2024) Design of inhibitors that target the Menin\u2013Mixed-Lineage Leukemia interaction. Computation 12:3. https:\/\/doi.org\/10.3390\/computation12010003","journal-title":"Computation"},{"key":"4890_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10637-009-9293-x","volume":"28","author":"TS Basu Baul","year":"2010","unstructured":"Basu Baul TS, Paul A, Pellerito L, Scopelliti M, Singh P, Verma P, De Vos D (2010) Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes. Invest New Drugs 28:587\u2013599. https:\/\/doi.org\/10.1007\/s10637-009-9293-x","journal-title":"Invest New Drugs"},{"key":"4890_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10637-009-9360-3","volume":"29","author":"TS Basu Baul","year":"2011","unstructured":"Basu Baul TS, Paul A, Pellerito L, Scopelliti M, Singh P, Verma P, Duthie A, De Vos D, Tiekink ER (2011) Dibutyltin(IV) complexes containing arylazobenzoate ligands: chemistry, in vitro cytotoxic effects on human tumor cell lines and mode of interaction with some enzymes. Invest New Drugs 29:285\u2013299. https:\/\/doi.org\/10.1007\/s10637-009-9360-3","journal-title":"Invest New Drugs"},{"key":"4890_CR8","doi-asserted-by":"publisher","unstructured":"Basu Baul TS, Dutta D, De Vos D, H\u00f6pfl H, Pooja, Singh P (2012) Advancement towards tin-based anticancer chemotherapeutics: structural modification and computer modeling approach to drug-enzyme interactions. Curr Top Med Chem 12:2810\u20132826. https:\/\/doi.org\/10.2174\/1568026611212240008","DOI":"10.2174\/1568026611212240008"},{"key":"4890_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103916","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S (2023) An empirical review on the resistance mechanisms of epidermal growth factor receptor inhibitors and predictive molecular biomarkers in colorectal cancer. Crit Rev Oncol Hematol. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103916","journal-title":"Crit Rev Oncol Hematol"},{"key":"4890_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.980141","volume":"12","author":"M Brindisi","year":"2022","unstructured":"Brindisi M, Kessler SM, Kumar V, Zwergel C (2022) Multi-target directed ligands for the treatment of cancer. Front Oncol 12:980141. https:\/\/doi.org\/10.3389\/fonc.2022.980141","journal-title":"Front Oncol"},{"key":"4890_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr2599","volume":"12","author":"C Cadenas","year":"2010","unstructured":"Cadenas C, Franckenstein D, Schmidt M, Gehrmann M, Hermes M, Geppert B, Schormann W, Maccoux LJ, Schug M, Schumann A (2010) Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res 12:1\u201315. https:\/\/doi.org\/10.1186\/bcr2599","journal-title":"Breast Cancer Res"},{"key":"4890_CR12","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","volume":"63","author":"DA Case","year":"2023","unstructured":"Case DA, Aktulga HM, Belfon K, Cerutti DS, Cisneros GA, Cruzeiro VWD, Forouzesh N, Giese TJ, G\u00f6Tz AW, Gohlke H (2023) AmberTools. J Chem Inf Model 63:6183\u20136191. https:\/\/doi.org\/10.1021\/acs.jcim.3c01153","journal-title":"J Chem Inf Model"},{"key":"4890_CR13","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.1073\/pnas.90.17.8131","volume":"90","author":"AY Chen","year":"1993","unstructured":"Chen AY, Yu C, Gatto B, Liu LF (1993) DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc Natl Acad Sci USA 90:8131\u20138135. https:\/\/doi.org\/10.1073\/pnas.90.17.8131","journal-title":"Proc Natl Acad Sci USA"},{"key":"4890_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/jcm9020360","volume":"9","author":"L Costantini","year":"2020","unstructured":"Costantini L, Molinari R, Farinon B, Merendino N (2020) Retinoic acids in the treatment of most lethal solid cancers. J Clin Med 9:360. https:\/\/doi.org\/10.3390\/jcm9020360","journal-title":"J Clin Med"},{"key":"4890_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70105","volume":"6","author":"YN Deng","year":"2025","unstructured":"Deng YN, Huang L, Gao S, Sheng Z, Luo Y, Zhang N, Syed SE, Dai R, Li Q, Fu X (2025) The SUMOylated RREB1 interacts with KDM1A to induce 5-fluorouracil resistance via upregulating thymidylate synthase and activating DNA damage response pathway in colorectal cancer. MedComm 6:e70105. https:\/\/doi.org\/10.1002\/mco2.70105","journal-title":"MedComm"},{"key":"4890_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12964-024-01607-9","volume":"22","author":"A Doostmohammadi","year":"2024","unstructured":"Doostmohammadi A, Jooya H, Ghorbanian K, Gohari S, Dadashpour M (2024) Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents. Cell Commun Signal 22:228. https:\/\/doi.org\/10.1186\/s12964-024-01607-9","journal-title":"Cell Commun Signal"},{"key":"4890_CR17","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.3390\/cancers14102446","volume":"14","author":"M Geindreau","year":"2022","unstructured":"Geindreau M, Bruchard M, Vegran F (2022) Role of cytokines and chemokines in angiogenesis in a tumor context. Cancers 14:2446. https:\/\/doi.org\/10.3390\/cancers14102446","journal-title":"Cancers"},{"key":"4890_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-pharmtox-052220-102509","volume":"62","author":"R Gencheva","year":"2022","unstructured":"Gencheva R, Arn\u00e9r ES (2022) Thioredoxin reductase inhibition for cancer therapy. Annu Rev Pharmacol Toxicol 62:177\u2013196. https:\/\/doi.org\/10.1146\/annurev-pharmtox-052220-102509","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4890_CR19","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.2174\/1389450117666160502151707","volume":"17","author":"K Gokduman","year":"2016","unstructured":"Gokduman K (2016) Strategies targeting DNA topoisomerase I in cancer chemotherapy: camptothecins, nanocarriers for camptothecins, organic non-camptothecin compounds and metal complexes. Curr Drug Targets 17:1928\u20131939. https:\/\/doi.org\/10.2174\/1389450117666160502151707","journal-title":"Curr Drug Targets"},{"key":"4890_CR20","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1021\/ct200909j","volume":"8","author":"AW Gotz","year":"2012","unstructured":"Gotz AW, Williamson MJ, Xu D, Poole D, Le Grand S, Walker RC (2012) Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. J Chem Inf Model 8:1542\u20131555. https:\/\/doi.org\/10.1021\/ct200909j","journal-title":"J Chem Inf Model"},{"key":"4890_CR21","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1039\/D1DT02851K","volume":"51","author":"GF Grawe","year":"2022","unstructured":"Grawe GF, Oliveira KM, Leite CM, De Oliveira TD, Honorato J, Ferreira AG, Castellano EE, Cominetti MR, Correa RS, Batista AA (2022) Ruthenium (II)-diphosphine complexes containing acylthiourea ligands are effective against lung and breast cancers. Dalton Trans 51:1489\u20131501. https:\/\/doi.org\/10.1039\/D1DT02851K","journal-title":"Dalton Trans"},{"key":"4890_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202204882","volume":"8","author":"S Gupta","year":"2023","unstructured":"Gupta S, Kumar A, Ghosh SK (2023) Novel azapodophyllotoxin induces DNA cleavage via groove binding: an advancement in exploration of anticancer activity of a known inhibitor of tubulin polymerization and topoisomerase. ChemistrySelect 8:e202204882. https:\/\/doi.org\/10.1002\/slct.202204882","journal-title":"ChemistrySelect"},{"key":"4890_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep08520","volume":"5","author":"S Harada","year":"2015","unstructured":"Harada S, Hiromori Y, Nakamura S, Kawahara K, Fukakusa S, Maruno T, Noda M, Uchiyama S, Fukui K, Nishikawa J-I (2015) Structural basis for PPAR\u03b3 transactivation by endocrine-disrupting organotin compounds. Sci Rep 5:8520. https:\/\/doi.org\/10.1038\/srep08520","journal-title":"Sci Rep"},{"key":"4890_CR24","doi-asserted-by":"publisher","DOI":"10.1063\/5.0019056","volume":"153","author":"X He","year":"2020","unstructured":"He X, Man VH, Yang W, Lee T-S, Wang J (2020) A fast and high-quality charge model for the next generation general AMBER force field. J Chem Phys 153:114502. https:\/\/doi.org\/10.1063\/5.0019056","journal-title":"J Chem Phys"},{"key":"4890_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cbdd.12122","volume":"82","author":"CH Heh","year":"2013","unstructured":"Heh CH, Othman R, Buckle MJ, Sharifuddin Y, Yusof R, Rahman NA (2013) Rational discovery of dengue type 2 non-competitive inhibitors. Chem Biol Drug Des 82:1\u201311. https:\/\/doi.org\/10.1111\/cbdd.12122","journal-title":"Chem Biol Drug Des"},{"key":"4890_CR26","volume-title":"Amber2022","author":"C Hmada","year":"2022","unstructured":"Hmada C, Belfon K, Ben-Shalom I, Berryman J, Brozell S, Cerutti D, Cheatham T, Cisneros G, Cruzeiro V, Darden T (2022) Amber2022. University of California, San Francisco"},{"key":"4890_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202405264","volume":"10","author":"A Ibrahim","year":"2025","unstructured":"Ibrahim A, Abu-Izneid T, Saleh A (2025) Design, synthesis, and biological evaluation of novel 3\u2032-deoxy-3\u2032-[1, 4-disubstituted-1, 2, 3-triazolyl] uridine analogues using CuAAC as potential human RNR inhibitors. ChemistrySelect 10:e202405264. https:\/\/doi.org\/10.1002\/slct.202405264","journal-title":"ChemistrySelect"},{"key":"4890_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nmeth.3658","volume":"13","author":"I Ivani","year":"2016","unstructured":"Ivani I, Dans PD, Noy A, P\u00e9rez A, Faustino I, Hospital A, Walther J, Andrio P, Go\u00f1i R, Balaceanu A (2016) Parmbsc1: a refined force field for DNA simulations. Nat Methods 13:55\u201358. https:\/\/doi.org\/10.1038\/nmeth.3658","journal-title":"Nat Methods"},{"key":"4890_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103629","volume":"99","author":"M Kadagathur","year":"2020","unstructured":"Kadagathur M, Devi GP, Grewal P, Sigalapalli DK, Makhal PN, Banerjee UC, Bathini NB, Tangellamudi ND (2020) Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: design, synthesis, biological evaluation and docking studies. Bioorg Chem 99:103629. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103629","journal-title":"Bioorg Chem"},{"key":"4890_CR30","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1021\/om301223k","volume":"32","author":"RA Khan","year":"2013","unstructured":"Khan RA, Asim A, Kakkar R, Gupta D, Bagchi V, Arjmand F, Tabassum S (2013) A chloro-bridged heterobimetallic (\u03b76-Arene) ruthenium\u2013organotin complex as an efficient topoisomerase I\u03b1 inhibitor. Organometallics 32:2546\u20132551. https:\/\/doi.org\/10.1021\/om301223k","journal-title":"Organometallics"},{"key":"4890_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105320","volume":"116","author":"S Khwaja","year":"2021","unstructured":"Khwaja S, Kumar K, Das R, Negi AS (2021) Microtubule associated proteins as targets for anticancer drug development. Bioinorg Chem 116:105320. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105320","journal-title":"Bioinorg Chem"},{"key":"4890_CR32","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.3390\/ijms24087233","volume":"24","author":"S Kumar","year":"2023","unstructured":"Kumar S, Sherman MY (2023) Resistance to TOP-1 inhibitors: good old drugs still can surprise us. Int J Mol Sci 24:7233. https:\/\/doi.org\/10.3390\/ijms24087233","journal-title":"Int J Mol Sci"},{"key":"4890_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cpc.2012.09.022","volume":"184","author":"S Le Grand","year":"2013","unstructured":"Le Grand S, G\u00f6tz AW, Walker RC (2013) SPFP: speed without compromise\u2014a mixed precision model for GPU accelerated molecular dynamics simulations. Comput Phys Commun 184:374\u2013380. https:\/\/doi.org\/10.1016\/j.cpc.2012.09.022","journal-title":"Comput Phys Commun"},{"key":"4890_CR34","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00018-009-0249-2","volume":"67","author":"A Le Maire","year":"2010","unstructured":"Le Maire A, Bourguet W, Balaguer P (2010) A structural view of nuclear hormone receptor: endocrine disruptor interactions. Cell Mol Life Sci 67:1219\u20131237. https:\/\/doi.org\/10.1007\/s00018-009-0249-2","journal-title":"Cell Mol Life Sci"},{"key":"4890_CR35","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jinorgbio.2009.05.006","volume":"103","author":"Y-C Lo","year":"2009","unstructured":"Lo Y-C, Ko T-P, Su W-C, Su T-L, Wang AH-J (2009) Terpyridine\u2013platinum (II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1. J Inorg Biochem 103:1082\u20131092. https:\/\/doi.org\/10.1016\/j.jinorgbio.2009.05.006","journal-title":"J Inorg Biochem"},{"key":"4890_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.chemosphere.2017.05.117","volume":"183","author":"S Mahanty","year":"2017","unstructured":"Mahanty S, Raghav D, Rathinasamy K (2017) In vitro evaluation of the cytotoxic and bactericidal mechanism of the commonly used pesticide triphenyltin hydroxide. Chemosphere 183:339\u2013352. https:\/\/doi.org\/10.1016\/j.chemosphere.2017.05.117","journal-title":"Chemosphere"},{"key":"4890_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2023.112363","volume":"248","author":"M Me\u0111edovi\u0107","year":"2023","unstructured":"Me\u0111edovi\u0107 M, Mijatovi\u0107 A, Bao\u0161i\u0107 R, Lazi\u0107 D, Milanovi\u0107 \u017d, Markovi\u0107 Z, Milovanovi\u0107 J, Arsenijevi\u0107 D, Stojanovi\u0107 B, Arsenijevi\u0107 M (2023) Synthesis, characterization, biomolecular interactions, molecular docking, and in vitro and in vivo anticancer activities of novel ruthenium (III) Schiff base complexes. J Inorg Biochem 248:112363. https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112363","journal-title":"J Inorg Biochem"},{"key":"4890_CR38","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1515\/pac-2019-1209","volume":"92","author":"ER Milaeva","year":"2020","unstructured":"Milaeva ER, Shpakovsky DB, Gracheva YA, Antonenko TA, Ksenofontova TD, Nikitin EA, Berseneva DA (2020) Novel selective anticancer agents based on Sn and Au complexes. Mini-review. Pure Appl Chem 92:1201\u20131216. https:\/\/doi.org\/10.1515\/pac-2019-1209","journal-title":"Pure Appl Chem"},{"key":"4890_CR39","doi-asserted-by":"publisher","unstructured":"Miller\u00a0III\u00a0IBR, Mcgee JTD, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA. py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8:3314\u20133321. https:\/\/doi.org\/10.1021\/ct300418h","DOI":"10.1021\/ct300418h"},{"key":"4890_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2019.117985","volume":"229","author":"Z Mirzaei-Kalar","year":"2020","unstructured":"Mirzaei-Kalar Z, Yavari A, Jouyban A (2020) Increasing DNA binding affinity of doxorubicin by loading on Fe3O4 nanoparticles: a multi-spectroscopic study. Spectrochim Acta A Mol Biomol Spectrosc 229:117985. https:\/\/doi.org\/10.1016\/j.saa.2019.117985","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"4890_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"key":"4890_CR42","doi-asserted-by":"publisher","unstructured":"Nath P, Datta A, Sen T, Adhikari S (2024) Emergence of metal-based anticancer therapeutics: a promising perspective, in: Biomarkers in Cancer Detection and Monitoring of Therapeutics. In: Sobti RC, Watanabe M, Aastha Sobti A (ed) Biomarkers in Cancer Detection and Monitoring of Therapeutics. Elsevier, pp 411\u2013450. https:\/\/doi.org\/10.1016\/B978-0-323-95114-2.00012-1.","DOI":"10.1016\/B978-0-323-95114-2.00012-1"},{"key":"4890_CR43","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/ci700388k","volume":"48","author":"R Othman","year":"2008","unstructured":"Othman R, Kiat TS, Khalid N, Yusof R, Newhouse EI, Newhouse JS, Alam M, Rahman NA (2008) Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites. J Chem Inf Model 48:1582\u20131591. https:\/\/doi.org\/10.1021\/ci700388k","journal-title":"J Chem Inf Model"},{"key":"4890_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41420-025-02418-8","volume":"11","author":"S Peng","year":"2025","unstructured":"Peng S, Long M, Chen Q, Yin Z, Zeng C, Zhang W, Wen Q, Zhang X, Ke W, Wu Y (2025) Perspectives on cancer therapy\u2014synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges. Cell Death Discov 11:179. https:\/\/doi.org\/10.1038\/s41420-025-02418-8","journal-title":"Cell Death Discov"},{"key":"4890_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0925-4439(02)00082-0","volume":"1587","author":"GJ Peters","year":"2002","unstructured":"Peters GJ, Backus HHJ, Freemantle S, Van Triest B, Codacci-Pisanelli G, Van Der Wilt CL, Smid K, Lunec J, Calvert AH, Marsh S (2002) Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1587:194\u2013205. https:\/\/doi.org\/10.1016\/S0925-4439(02)00082-0","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"4890_CR46","doi-asserted-by":"publisher","first-page":"W591","DOI":"10.1093\/nar\/gkaa367","volume":"48","author":"T Ra\u010dek","year":"2020","unstructured":"Ra\u010dek T, Schindler O, Tou\u0161ek D, Horsk\u00fd V, Berka K, Ko\u010da J, Svobodov\u00e1 R (2020) Atomic charge calculator II: web-based tool for the calculation of partial atomic charges. Nucleic Acids Res 48:W591\u2013W596. https:\/\/doi.org\/10.1093\/nar\/gkaa367","journal-title":"Nucleic Acids Res"},{"key":"4890_CR47","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1007\/s12010-022-03862-3","volume":"194","author":"K Rajeshwari","year":"2022","unstructured":"Rajeshwari K, Vasantha P, Shekhar B, Anantha Lakshmi P (2022) Metformin-derived water-soluble cobalt complexes: thermal, spectroscopic, DNA interaction, and molecular docking studies. Appl Biochem Biotechnol 194:2650\u20132671. https:\/\/doi.org\/10.1007\/s12010-022-03862-3","journal-title":"Appl Biochem Biotechnol"},{"key":"4890_CR48","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/molecules23051038","volume":"23","author":"D Ram\u00edrez","year":"2018","unstructured":"Ram\u00edrez D, Caballero J (2018) Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data? Molecules 23:1038. https:\/\/doi.org\/10.3390\/molecules23051038","journal-title":"Molecules"},{"key":"4890_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejmech.2018.02.009","volume":"148","author":"V Rodriguez-Fanjul","year":"2018","unstructured":"Rodriguez-Fanjul V, Lopez-Torres E, Mendiola MA, Pizarro AM (2018) Gold (III) bis (thiosemicarbazonate) compounds in breast cancer cells: cytotoxicity and thioredoxin reductase targeting. Eur J Med Chem 148:372\u2013383. https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.009","journal-title":"Eur J Med Chem"},{"key":"4890_CR50","doi-asserted-by":"publisher","unstructured":"Roe DR, Cheatham\u00a0III TE (2013) PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9:3084\u20133095. https:\/\/doi.org\/10.1021\/ct400341p","DOI":"10.1021\/ct400341p"},{"key":"4890_CR51","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2012","unstructured":"Salomon-Ferrer R, Goetz A, Poole D, Grand L, Walker R (2012) Routine microsecond molecular dynamics simulations with AMBER-PartII: particle mesh Ewald. J Chem Theory Comput 9:3878\u20133888. https:\/\/doi.org\/10.1021\/ct400314y","journal-title":"J Chem Theory Comput"},{"key":"4890_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/13543776.2021.1879051","volume":"31","author":"A Selas","year":"2021","unstructured":"Selas A, Martin-Encinas E, Fuertes M, Masdeu C, Rubiales G, Palacios F, Alonso C (2021) A patent review of topoisomerase I inhibitors (2016\u2013present). Expert Opin Ther Pat 31:473\u2013508. https:\/\/doi.org\/10.1080\/13543776.2021.1879051","journal-title":"Expert Opin Ther Pat"},{"key":"4890_CR53","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.2174\/1381612824666181106101448","volume":"24","author":"C Selvaraj","year":"2018","unstructured":"Selvaraj C, Singh SK (2018) Computational and experimental binding mechanism of DNA-drug interactions. Curr Pharm Des 24:3739\u20133757. https:\/\/doi.org\/10.2174\/1381612824666181106101448","journal-title":"Curr Pharm Des"},{"key":"4890_CR54","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/cancers16040680","volume":"16","author":"NK Sharma","year":"2024","unstructured":"Sharma NK, Bahot A, Sekar G, Bansode M, Khunteta K, Sonar PV, Hebale A, Salokhe V, Sinha BK (2024) Understanding cancer\u2019s defense against topoisomerase-active drugs: a comprehensive review. Cancers 16:680. https:\/\/doi.org\/10.3390\/cancers16040680","journal-title":"Cancers"},{"key":"4890_CR55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1039\/c2mt00137c","volume":"4","author":"S Tabassum","year":"2012","unstructured":"Tabassum S, Mathur S, Arjmand F, Mishra K, Banerjee K (2012) Design, synthesis, characterization and DNA-binding studies of a triphenyltin (IV) complex of N-glycoside (GATPT), a sugar based apoptosis inducer: in vitro and in vivo assessment of induction of apoptosis by GATPT. Metallomics 4:205\u2013217. https:\/\/doi.org\/10.1039\/c2mt00137c","journal-title":"Metallomics"},{"key":"4890_CR56","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3892\/ijo.2013.2135","volume":"43","author":"K Takahashi","year":"2013","unstructured":"Takahashi K, Tanaka M, Inagaki A, Wanibuchi H, Izumi Y, Miura K, Nagayama K, Shiota M, Iwao H (2013) Establishment of a 5-fluorouracil-resistant triple-negative breast cancer cell line. Int J Oncol 43:1985\u20131991. https:\/\/doi.org\/10.3892\/ijo.2013.2135","journal-title":"Int J Oncol"},{"key":"4890_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107942","volume":"230","author":"N Takahashi","year":"2022","unstructured":"Takahashi N, Saito D, Hasegawa S, Yamasaki M, Imai M (2022) Vitamin A in health care: suppression of growth and induction of differentiation in cancer cells by vitamin A and its derivatives and their mechanisms of action. Pharmacol Ther 230:107942. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107942","journal-title":"Pharmacol Ther"},{"key":"4890_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10822-023-00499-0","volume":"37","author":"M Taylor","year":"2023","unstructured":"Taylor M, Ho J (2023) MM\/GBSA prediction of relative binding affinities of carbonic anhydrase inhibitors: effect of atomic charges and comparison with Autodock4(Zn). J Comput Aided Mol Des 37:167\u2013182. https:\/\/doi.org\/10.1007\/s10822-023-00499-0","journal-title":"J Comput Aided Mol Des"},{"key":"4890_CR59","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2019","unstructured":"Tian C, Kasavajhala K, Belfon KA, Raguette L, Huang H, Migues AN, Bickel J, Wang Y, Pincay J, Wu Q (2019) ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput 16:528\u2013552. https:\/\/doi.org\/10.1021\/acs.jctc.9b00591","journal-title":"J Chem Theory Comput"},{"key":"4890_CR60","doi-asserted-by":"publisher","unstructured":"Tiang YP (2015) Interactions of G-quadruplex binders and Topoisomerase I inhibitors in cancer cells. Alma Mater Studiorum Universit\u00e0 di Bologna. Dottorato di ricerca in Biologia cellulare e molecolare. https:\/\/doi.org\/10.6092\/unibo\/amsdottorato\/6951","DOI":"10.6092\/unibo\/amsdottorato\/6951"},{"key":"4890_CR61","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1158\/1535-7163.MCT-16-0818","volume":"17","author":"F Wang","year":"2018","unstructured":"Wang F, Zhang H, Ma A-H, Yu W, Zimmermann M, Yang J, Hwang SH, Zhu D, Lin T-Y, Malfatti M (2018) COX-2\/sEH dual inhibitor PTUPB potentiates the antitumor efficacy of cisplatin. Mol Cancer Ther 17:474\u2013483. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0818","journal-title":"Mol Cancer Ther"},{"key":"4890_CR62","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.trecan.2022.01.018","volume":"8","author":"BM Warfield","year":"2022","unstructured":"Warfield BM, Reigan P (2022) Multifunctional role of thymidine phosphorylase in cancer. Trends Cancer 8:482\u2013493. https:\/\/doi.org\/10.1016\/j.trecan.2022.01.018","journal-title":"Trends Cancer"},{"key":"4890_CR63","doi-asserted-by":"publisher","first-page":"301","DOI":"10.33549\/physiolres.935007","volume":"72","author":"Z Wenqi","year":"2023","unstructured":"Wenqi Z, Zhuang P, Yixi C, Yi W, Zhong M, Yongzhi L (2023) \u201cDouble-edged sword\u201d effect of reactive oxygen species (ROS) in tumor development and carcinogenesis. Physiol Res 72:301\u2013317. https:\/\/doi.org\/10.33549\/physiolres.935007","journal-title":"Physiol Res"},{"key":"4890_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.574","volume":"6","author":"J Xu","year":"2015","unstructured":"Xu J, Eriksson S, Cebula M, Sandalova T, Hedstr\u00f6m E, Pader I, Cheng Q, Myers C, Antholine W, Nagy P (2015) The conserved Trp114 residue of thioredoxin reductase 1 has a redox sensor-like function triggering oligomerization and crosslinking upon oxidative stress related to cell death. Cell Death Dis 6:e1616-e1616. https:\/\/doi.org\/10.1038\/cddis.2014.574","journal-title":"Cell Death Dis"},{"key":"4890_CR65","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/14728222.2024.2341630","volume":"28","author":"PA Yakkala","year":"2024","unstructured":"Yakkala PA, Rahaman S, Soukya PL, Begum SA, Kamal A (2024) An update on the development on tubulin inhibitors for the treatment of solid tumors. Expert Opin Ther Targets 28:193\u2013220. https:\/\/doi.org\/10.1080\/14728222.2024.2341630","journal-title":"Expert Opin Ther Targets"},{"key":"4890_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.poly.2021.115069","volume":"198","author":"ENM Yusof","year":"2021","unstructured":"Yusof ENM, Ravoof TB, Page AJ (2021) Cytotoxicity of tin (IV)-based compounds: a review. Polyhedron 198:115069. https:\/\/doi.org\/10.1016\/j.poly.2021.115069","journal-title":"Polyhedron"},{"key":"4890_CR67","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/01.RES.0000130525.37646.a7","volume":"94","author":"R Zhang","year":"2004","unstructured":"Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, Bradley J, Min W (2004) Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 94:1483\u20131491. https:\/\/doi.org\/10.1161\/01.RES.0000130525.37646.a7","journal-title":"Circ Res"},{"key":"4890_CR68","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2174\/1568026616666161117112604","volume":"17","author":"X Zhang","year":"2017","unstructured":"Zhang X, Perez-Sanchez H, Lightstone FC (2017) A comprehensive docking and MM\/GBSA rescoring study of ligand recognition upon binding antithrombin. Curr Top Med Chem 17:1631\u20131639. https:\/\/doi.org\/10.2174\/1568026616666161117112604","journal-title":"Curr Top Med Chem"},{"key":"4890_CR69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/ars.2022.0074","volume":"38","author":"J Zhang","year":"2023","unstructured":"Zhang J, Li X, Zhao Z, Cai W, Fang J (2023) Thioredoxin signaling pathways in cancer. Antioxid Redox Signal 38:403\u2013424. https:\/\/doi.org\/10.1089\/ars.2022.0074","journal-title":"Antioxid Redox Signal"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04890-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:16:16Z","timestamp":1776312976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04890-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4890"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04890-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}